The performance of companies tied to Sildenafil's past presents a challenging investment picture . While the initial boom generated substantial returns , generic alternatives have significantly impacted https://businessbookmark.com/story7218919/copyright-s-flagship-product-and-pharma-a-uncertain-opportunity